Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Momentary Coping Prompts and Hair Steroids in College Students (REACT-Bio)

2 novembre 2026 mis à jour par: University of Florida

REACT Biomarker and Extended-Measures Study: Hair Steroids, Psychosocial Moderators, and Momentary Reactive Behavior in College Students

This study looks at the moments when college students feel a strong emotional swing, and how those moments relate to reacting online when upset, drinking alcohol, and eating in response to emotions. Participants wear a wrist device and answer brief check-ins on their phone several times a day for five weeks in total, starting with a 1-week run-in. During the following 4 weeks, a study app sometimes sends a short coping message at moments when check-in answers suggest emotions are shifting quickly. Whether a message is sent at any given moment is decided at random, and the study compares what participants do in the short window afterward. An optional part of the study collects one small hair sample, which is tested for two hormones related to stress and to status-linked behavior, so the researchers can see whether longer-term hormone levels relate to how people respond in the moment. The study is a pilot designed to test whether the approach works and to estimate how large its effects are.

Aperçu de l'étude

Description détaillée

REACT is a five-week micro-randomized trial in University of Florida students age 18 to 24. Participants complete a baseline battery, wear a Garmin Venu 3, and respond to five to six smartphone check-ins per day. Week one is a no-prompt run-in that establishes each participant's own baseline distribution of momentary affective variability, indexed by the mean square of successive differences on consecutive affect ratings. From week two through week five, the app evaluates up to six decision points per day. A decision point is flagged when the participant's current variability exceeds their own 80th percentile threshold, computed within person rather than against a group average. At each available decision point the app randomizes with probability 0.5 whether to deliver a brief coping message, and if so selects a message type from those eligible in that context. Availability rules exclude sleep, stale device data, a 60-minute cooldown, a daily cap, and any safety override. Proximal outcomes are drawn from the first check-in within two hours after the decision point. Analysis uses weighted and centered least squares to estimate causal excursion effects, with pre-specified moderators. An optional sub-study collects a single hair sample at the enrollment visit, assayed for cortisol and testosterone, to test whether early-life adversity moderates the association between chronic stress physiology and momentary reactive behavior.

Type d'étude

Interventionnel

Inscription (Estimé)

80

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Lieux d'étude

    • Florida
      • Gainesville, Florida, États-Unis, 32611
        • Recrutement
        • University of Florida
        • Contact:
          • Yonghwan Chang, PhD
          • Numéro de téléphone: 352-294-1664
          • E-mail: yhchang@ufl.edu
        • Chercheur principal:
          • Yonghwan Chang, PhD

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 24 ans (Adulte)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Currently enrolled University of Florida student
  • Age 18 to 24 years
  • Owns a smartphone used daily
  • Willing to wear a wrist-worn device and complete brief check-ins several times daily for approximately five weeks
  • For the optional hair biomarker sub-study only: at least approximately 1 cm of hair at the posterior vertex, no scalp wound, rash, or dermatologic treatment at the collection site, and natural hair growth accessible at the collection site

Exclusion Criteria:

  • Varsity student-athlete governed by the university athletic association
  • Unable to complete study procedures in English

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: La prévention
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation croisée
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Coping prompt delivered

Decision points at which the randomization outcome is to deliver a brief cognitive-behavioral or acceptance-based coping message. Message type is selected at random from those eligible in the participant's current context. Every participant contributes decision points to this condition.

A single short message of one to three sentences delivered to the participant's smartphone at a randomized decision point, taking roughly fifteen to thirty seconds to read. Messages apply cognitive-behavioral techniques including thought records, perspective-taking, decatastrophizing, cost-benefit checks, implementation intentions, and behavioral redirection, or acceptance-based techniques including cognitive defusion, acceptance, values anchoring, urge surfing, and present-moment grounding. Delivery is capped at four messages per day with a minimum sixty-minute interval and is confined to participant-set waking hours. Messages may be dismissed without responding.

Comparateur actif: No coping prompt or active control message

Decision points at which the randomization outcome is not to deliver a coping message. A brief neutral, non-directive acknowledgment message may be delivered as an active control so that receiving any message can be separated from receiving a coping message. Every participant contributes decision points to this condition.

A brief neutral acknowledgment message matched to the coping messages on delivery mechanism and approximate length, containing no coping technique or behavioral suggestion.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Momentary urge to post or reply reactively, score on a 7-point scale.
Délai: Within 2 hours after each randomized decision point, across weeks 2 to 5.

Self-reported urge to post or reply about something upsetting, rated 1 to 7 at the first check-in within two hours after a randomized decision point. Higher scores indicate greater urge. Analyzed as a causal excursion effect comparing decision points at which a coping message was delivered with those at which it was not.

Within 2 hours after each randomized decision point, across weeks 2 to 5.
Momentary urge to drink alcohol, score on a 7-point scale.
Délai: Within 2 hours after each randomized decision point, across weeks 2 to 5.

Self-reported current urge to drink alcohol, rated 1 to 7 at the first check-in within two hours after a randomized decision point. Higher scores indicate greater urge. Analyzed as a causal excursion effect.

Within 2 hours after each randomized decision point, across weeks 2 to 5.
Momentary emotional influence on eating, score on a 7-point scale.
Délai: Within 2 hours after each randomized decision point, across weeks 2 to 5

Self-reported rating of how much emotions influenced eating since the previous check-in, rated 1 to 7 at the first check-in within two hours after a randomized decision point. Analyzed as a causal excursion effect.

Within 2 hours after each randomized decision point, across weeks 2 to 5

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Momentary reactive online behavior since the previous check-in, self-reported occurrence
Délai: Within 2 hours after each randomized decision point, across weeks 2 to 5

Self-reported occurrence of posting or replying while upset since the previous check-in, reported yes or no at the first check-in within two hours after a randomized decision point.

Within 2 hours after each randomized decision point, across weeks 2 to 5
Number of standard drinks consumed since the previous check-in, self-reported count
Délai: Within 2 hours after each randomized decision point, across weeks 2 to 5

Self-reported number of standard drinks consumed since the previous check-in.

Within 2 hours after each randomized decision point, across weeks 2 to 5
Loss-of-control eating rating, score on a 7-point scale.
Délai: Within 2 hours after each randomized decision point, across weeks 2 to 5

Self-reported sense of losing control while eating since the previous check-in, rated 1 to 7.

Within 2 hours after each randomized decision point, across weeks 2 to 5
Proportion of scheduled check-ins completed.
Délai: Through study completion, approximately 5 weeks per participant.

Number of completed check-ins divided by number of scheduled check-ins. Pre-registered feasibility benchmark is 75 percent.

Through study completion, approximately 5 weeks per participant.
Proportion of delivered prompts receiving a response
Délai: Through study completion, approximately 5 weeks per participant.

Number of prompts receiving a rating response divided by number of prompts delivered. Pre-registered benchmark is 60 percent.

Through study completion, approximately 5 weeks per participant.
Proportion of waking hours with valid wearable data.
Délai: Through study completion, approximately 5 weeks per participant.

Hours of valid physiological data divided by estimated waking hours. Pre-registered benchmark is 80 percent.

Through study completion, approximately 5 weeks per participant.
Proportion of enrolled participants retained to study end.
Délai: Through study completion, approximately 5 weeks per participant.

Number of participants completing the study divided by number enrolled. Pre-registered benchmark is 85 percent.

Through study completion, approximately 5 weeks per participant.
Proportion of sub-study participants providing a usable hair sample.
Délai: Enrollment visit

Number of usable hair samples divided by number of sub-study participants. Pre-registered benchmark is 90 percent.

Enrollment visit
Prompt helpfulness rating, score on a 7-point scale.
Délai: Week 3 and end of study, approximately week 5.

Participant rating of how helpful the coping prompts were, rated 1 to 7.

Week 3 and end of study, approximately week 5.
System Usability Scale total score
Délai: End of study, approximately week 5.

System Usability Scale (Brooke, 1996) total score, range 0 to 100, higher scores indicating better usability.

End of study, approximately week 5.

Autres mesures de résultats

Mesure des résultats
Description de la mesure
Délai
Exploratory: concentration of hair cortisol, pg/mg.
Délai: Enrollment visit, single hair sample reflecting approximately the prior 3 months.

Hair cortisol concentration in picograms per milligram assayed from a single hair sample. This measure is exploratory.

Enrollment visit, single hair sample reflecting approximately the prior 3 months.
Exploratory: concentration of hair testosterone, pg/mg.
Délai: Enrollment visit, single hair sample reflecting approximately the prior 3 months.

Hair testosterone concentration in picograms per milligram assayed from a single hair sample. This measure is exploratory.

Enrollment visit, single hair sample reflecting approximately the prior 3 months.
Exploratory: correlation between hair cortisol concentration and momentary reactive behavior score, stratified by adverse childhood experiences score.
Délai: Baseline hair sample, with momentary outcomes across weeks 2 to 5.

Correlation between hair cortisol concentration (pg/mg) and momentary reactive behavior score (7-point scale), examined separately by adverse childhood experiences score measured with the ACE questionnaire (range 0 to 10). This measure is exploratory.

Baseline hair sample, with momentary outcomes across weeks 2 to 5.
Exploratory: correlation between hair testosterone concentration and momentary reactive behavior score.
Délai: Baseline hair sample, with momentary outcomes across weeks 2 to 5

Correlation between hair testosterone concentration (pg/mg) and momentary reactive behavior score (7-point scale). This measure is exploratory.

Baseline hair sample, with momentary outcomes across weeks 2 to 5
Exploratory: eating when not hungry, self-reported occurrence
Délai: 60 to 120 minutes after each randomized decision point, across weeks 2 to 5

Whether the participant reported eating since the previous check-in after rating their hunger just before eating at 3 or lower on a 1 to 7 scale, recorded at the outcome check-in after a randomized decision point and analyzed as a causal excursion effect. Collected only from participants who agreed to the Amendment 1 check-in items.

60 to 120 minutes after each randomized decision point, across weeks 2 to 5
Exploratory: loss of control while eating, self-reported occurrence
Délai: 60 to 120 minutes after each randomized decision point, across weeks 2 to 5

Whether the participant rated loss of control over eating, or feeling unable to stop once started, at 3 or higher on a 1 to 5 scale for an eating episode since the previous check-in, recorded at the outcome check-in after a randomized decision point. Collected only from participants who agreed to the Amendment 1 check-in items.

60 to 120 minutes after each randomized decision point, across weeks 2 to 5
Exploratory: eating highly palatable foods, self-reported occurrence
Délai: 60 to 120 minutes after each randomized decision point, across weeks 2 to 5

Whether an eating episode since the previous check-in included sweets or desserts, salty snacks, fast food or sugary drinks, recorded at the outcome check-in after a randomized decision point. Collected only from participants who agreed to the Amendment 1 check-in items.

60 to 120 minutes after each randomized decision point, across weeks 2 to 5
Exploratory: emotional eating, self-reported occurrence
Délai: 60 to 120 minutes after each randomized decision point, across weeks 2 to 5

Whether the participant rated eating because of how they were feeling at 3 or higher on a 1 to 5 scale for an eating episode since the previous check-in, recorded at the outcome check-in after a randomized decision point. Collected only from participants who agreed to the Amendment 1 check-in items.

60 to 120 minutes after each randomized decision point, across weeks 2 to 5
Exploratory: momentary desire to eat something tasty, score on a 7-point scale
Délai: 60 to 120 minutes after each randomized decision point, across weeks 2 to 5

Current desire to eat something tasty, rated 1 to 7 at the outcome check-in after a randomized decision point. Higher scores indicate stronger desire. Collected only from participants who agreed to the Amendment 1 check-in items.

60 to 120 minutes after each randomized decision point, across weeks 2 to 5
Exploratory: change in eating disorder symptoms, EDE-QS total score
Délai: Baseline and end of study, approximately week 5

Eating Disorder Examination Questionnaire Short (EDE-QS), 12 items, total score 0 to 36, higher scores indicating more eating disorder symptoms. Change from baseline to end of study. Added under Amendment 1.

Baseline and end of study, approximately week 5
Exploratory: change in insomnia severity, Insomnia Severity Index total score
Délai: Baseline and end of study, approximately week 5

Insomnia Severity Index, 7 items, total score 0 to 28, higher scores indicating more severe insomnia. Change from baseline to end of study. Added under Amendment 1.

Baseline and end of study, approximately week 5
Exploratory: change in anxiety symptoms, GAD-7 total score
Délai: Baseline and end of study, approximately week 5

Generalized Anxiety Disorder 7-item scale, total score 0 to 21, higher scores indicating more anxiety. Change from baseline to end of study. Added under Amendment 1.

Baseline and end of study, approximately week 5
Exploratory: change in mental wellbeing, SWEMWBS score
Délai: Baseline and end of study, approximately week 5

Short Warwick-Edinburgh Mental Wellbeing Scale, 7 items, raw score 7 to 35, higher scores indicating better wellbeing. Change from baseline to end of study. Added under Amendment 1.

Baseline and end of study, approximately week 5
Exploratory: change in perceived stress, PSS-10 total score
Délai: Baseline and end of study, approximately week 5

Perceived Stress Scale, 10 items, total score 0 to 40, higher scores indicating more perceived stress. Change from baseline to end of study; the end-of-study assessment was added under Amendment 1.

Baseline and end of study, approximately week 5

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Yonghwan Chang, PhD, University of Florida

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

21 septembre 2026

Achèvement primaire (Estimé)

1 mai 2027

Achèvement de l'étude (Estimé)

1 décembre 2027

Dates d'inscription aux études

Première soumission

17 août 2026

Première soumission répondant aux critères de contrôle qualité

20 août 2026

Première publication (Réel)

24 août 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

5 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

2 novembre 2026

Dernière vérification

1 octobre 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

OUI

Description du régime IPD

De-identified data from participants who agree to data sharing on the consent form, a separate choice that does not affect participation or payment. The deposit holds survey and check-in responses, app timing records, wearable sensor data and hair assay values. Before deposit we remove names, contact information, email and IP addresses, device serial numbers, free-text answers and interview recordings, convert calendar dates to study days, and replace each study code with a new random number. The key linking study codes to identities stays at the University of Florida and is never shared. No hair or other specimens are banked.

Délai de partage IPD

After the main results are published. ICPSR keeps the files indefinitely. A participant may withdraw the choice at any time before deposit.

Critères d'accès au partage IPD

Restricted-use files at the Inter-university Consortium for Political and Social Research (ICPSR), University of Michigan, released only to researchers who sign its data use agreement, which forbids any attempt to identify participants.

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner